Researchers analyzed 11 different studies to understand weight outcomes after stopping anti-obesity medications called glucagon-like peptide-1 receptor agonists, or GLP-1s, which mimic the GLP-1 hormone that is produced in the gut after eating
has acted as a consultant of Boehringer Ingelheim, Dexcom, Eli Lilly, Novo Nordisk and Sanofi and received speaking fees from Eli Lilly, Novo Nordisk and Sanofi
Our peptides are administered via a small subcutaneous injection (similar to an insulin shot), typically done once daily or a few times a week.
Our Precision Peptide Genetic Test may help provide context about your predisposition in key peptide pathwayssuch as GLP1R rs6923761 and GIPR rs1800437 variantsthat could inform how you respond to dual-receptor approaches versus monotherapy, should be interpreted with your qualified healthcare provider
How to choose the format or type of L-carnitine